Back
PDS Biotechnology Vs. Seres Therapeutics Industry Stock Comparison
Sell
44
PDSB
PDS Biotechnology
Last Price:
3.24
Seasonality Move:
3.52%
Sell
45
MCRB
Seres Therapeutics
Last Price:
0.80
Seasonality Move:
-5.38%
Sell
44
PDS Biotechnology (PDSB)
is a Sell
Is PDS Biotechnology a Buy, Sell or Hold?
- The current PDS Biotechnology [PDSB] share price is $3.20. The Score for PDSB is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- PDSB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Seres Therapeutics (MCRB)
is a Sell
Is Seres Therapeutics a Buy, Sell or Hold?
- The current Seres Therapeutics [MCRB] share price is $0.82. The Score for MCRB is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- MCRB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PDSB Stock Price Chart
What is PDS Biotechnology's stock price today?
-
The PDS Biotechnology share price today is $3.20
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PDSB is experiencing slight selling pressure.
MCRB Stock Price Chart
What is Seres Therapeutics's stock price today?
-
The Seres Therapeutics share price today is $0.82
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MCRB is experiencing slight buying pressure.
PDSB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 47.46 | Sell |
| Chaikin Money Flow: | -125040 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.11 - 3.67) | Sell |
| Bollinger Bands (100): | (2.91 - 3.65) | Sell |
MCRB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 49.85 | Sell |
| Chaikin Money Flow: | 1866965 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.74 - 0.88) | Buy |
| Bollinger Bands (100): | (0.74 - 1.12) | Sell |
PDSB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.18 | Buy |
| 20-day SMA: | 3.3 | Sell |
| 50-day SMA: | 3.25 | Sell |
| 200-day SMA: | 3.77 | Sell |
| 8-day EMA: | 3.21 | Sell |
| 20-day EMA: | 3.26 | Sell |
| 50-day EMA: | 3.29 | Sell |
| 200-day EMA: | 3.76 | Sell |
MCRB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.76 | Buy |
| 20-day SMA: | 0.79 | Buy |
| 50-day SMA: | 0.88 | Sell |
| 200-day SMA: | 0.93 | Sell |
| 8-day EMA: | 0.79 | Buy |
| 20-day EMA: | 0.81 | Buy |
| 50-day EMA: | 0.87 | Sell |
| 200-day EMA: | 1.19 | Sell |
PDS Biotechnology Earnings Growth & PDSB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and a decrease next year of $0.24 per share.
Seres Therapeutics Earnings Growth & MCRB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.31 per share, and an increase next year of $0.18 per share.
PDS Biotechnology Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Seres Therapeutics Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||